IP Library Granted Patent US 8,263,397
Granted Patent B2
US 8,263,397 · App. 12/722,968 · Granted Sep 11, 2012

Female specific insect expression system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,397
App. No.
12/722,968
Granted
Sep 11, 2012
Kind
B2
Abstract

The present invention provides an insect expression system that may be used to provide biological control of pest insects and control transmission of infectious diseases transmitted to the human population by insects.

Claims (14)

1. An expression system comprising:

(a) an enhancer sequence consisting of SEQ ID NO: 1;

(b) a heterologous promoter operably linked to the enhancer element of (a);

(c) one or more heterologous nucleic acid sequences for expression in a mosquito operably linked to the promoter in (b);

wherein, the enhancer element directs female-specific expression of the heterologous nucleic acid sequence at a level greater than six fold higher in female than in male mosquitoes.

2. The expression system of claim 1 , wherein the heterologous nucleic acid is selected from the group consisting of nucleic acids encoding a transactivation factor, a reporter, and an effector.

3. The expression system of claim 2 , wherein the effector is a cell death factor or a factor that provides a selective advantage to the mosquito.

4. The expression system of claim 1 , wherein the enhancer element further directs expression of the heterologous nucleic acid sequence in the fat body of the female mosquito.

5. The expression system of claim 1 , wherein the enhancer element further directs expression of the heterologous nucleic acid sequence at a late larval stage and early adult stage of mosquito development.

6. The insect expression system of claim 1 , wherein the expression system is incorporated into a vector.

7. The expression system of claim 1 , wherein the female-specific expression of the heterologous nucleic acid sequence is at a level greater than 10 fold higher in female than in male mosquitoes.

8. The expression system of claim 1 , wherein the female-specific expression of the heterologous nucleic acid sequence is at a level greater than 25 fold higher in female than in male mosquitoes.

9. The expression system of claim 1 , wherein the female-specific expression of the heterologous nucleic acid sequence is at a level greater than 100 fold higher in female than in male mosquitoes.

10. The expression system of claim 1 , wherein the mosquitoes is the Aedes aegypti mosquito.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2018
From: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BIOVENTURES, LLC
Reel/Frame 047667/0515 →
CONFIRMATORY LICENSE Recorded Sep 14, 2010
From: UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024979/0575 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2010
From: BENES, HELEN
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 024119/0961 →